Home » Topics » Regulatory

Regulatory
RSS

New formulation of selegiline

Sep. 13, 1996

Known antipsychotic claimed for drug dependence

Sep. 13, 1996

Rapamycin in anemia

Sep. 13, 1996

Novel treatment for bone loss

Sep. 13, 1996

U.S. approval for glaucoma medication

Sep. 13, 1996

Seratrodast claimed for the treatment of atopic dermatitis

Sep. 13, 1996

Liarozole claimed for inhibiting calcitriol metabolism

Sep. 13, 1996

Controlled-release oral analgesic formulation claimed by Euroceltique

Sep. 13, 1996

Moxisylyte to treat erectile dysfunction

Sep. 6, 1996

Cimetidine for treatment of interstitial cystitis

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...